Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study

被引:38
作者
Achterberg, Sefanja [1 ]
Cramer, Maarten J. M. [2 ]
Kappelle, L. Jaap [1 ]
de Borst, Gert Jan [3 ]
Visseren, Frank L. J. [4 ]
van der Graaf, Yolanda [5 ]
Algra, Ale [1 ,5 ]
机构
[1] Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Cardiol, NL-3508 GA Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Vasc Surg, NL-3508 GA Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Dept Vasc Med, NL-3508 GA Utrecht, Netherlands
[5] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands
来源
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2010年 / 17卷 / 04期
关键词
ORAL ANTICOAGULANT-THERAPY; BLEEDING COMPLICATIONS; OUTPATIENTS; PREVENTION; PREVALENCE;
D O I
10.1097/HJR.0b013e3283361ce6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Atherosclerosis causes coronary artery disease (CAD), cerebrovascular disease (CVD) or peripheral arterial obstructive disease (PAOD). The risk of new vascular events and mortality is high. Direct comparisons of vascular event rates are scarce. Methods and results Vascular risk factors and outcome events of 3563 patients from a university hospital presenting with nondisabling CAD, CVD or PAOD were compared with regression analyses, adjusted for age and sex (median follow-up, 3.9 years). The primary outcome was the composite of myocardial infarction, stroke and vascular death. The risk among the three groups of outcomes was compared using the Cox regression analysis. At baseline, CAD patients were the most obese; PAOD patients smoked the most and suffered more often from hypertension and hyperlipidaemia. The average rate of vascular events was 2.5% per year; the hazard ratio (HR) of CVD/CAD was 1.7 [95% confidence interval (CI): 1.3-2.2] and PAOD/CAD was 1.8 (95% CI: 1.5-2.0). PAOD patients had a higher risk for coronary events than CAD (HR: 1.6; 95% CI: 1.2-2.1). Patients with CVD or PAOD had a higher risk for major bleeding than CAD patients (HR: 2.1; 95% CI: 1.4-3.2). Conclusion Patients with a recent CVD or PAOD have almost twice the risk for future vascular events than those with CAD. Eur J Cardiovasc Prev Rehabil 17: 424-430 (C) 2010 The European Society of Cardiology
引用
收藏
页码:424 / 430
页数:7
相关论文
共 23 条
[11]   Outcome events in patients with claudication: A 15-year study in 2777 patients [J].
Muluk, SC ;
Muluk, VS ;
Kelley, ME ;
Whittle, JC ;
Tierney, JA ;
Webster, MW ;
Makaroun, MS .
JOURNAL OF VASCULAR SURGERY, 2001, 33 (02) :251-257
[12]   Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications [J].
Norman, PE ;
Eikelboom, JW ;
Hankey, GJ .
MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (03) :150-154
[13]   Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT) [J].
Palareti, G ;
Leali, N ;
Coccheri, S ;
Poggi, M ;
Manotti, C ;
DAngelo, A ;
Pengo, V ;
Erba, N ;
Moia, M ;
Ciavarella, N ;
Devote, G ;
Berrettini, M ;
Musolesi, S .
LANCET, 1996, 348 (9025) :423-428
[14]   ROLES OF P2-PURINOCEPTORS IN THE CARDIOVASCULAR-SYSTEM [J].
RALEVIC, V ;
BURNSTOCK, G .
CIRCULATION, 1991, 84 (01) :1-14
[15]   Thrombus formation on atherosclerotic plaques: Pathogenesis and clinical consequences [J].
Rauch, U ;
Osende, JI ;
Fuster, V ;
Badimon, JJ ;
Fayad, Z ;
Chesebro, JH .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (03) :224-238
[16]   Interventions for smoking cessation in hospitalised patients (Withdrawn Paper. 2007, art. no. CD001837) [J].
Rigotti, N. A. ;
Munafo, M. R. ;
Stead, L. F. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (03)
[17]   Second Manifestations of ARTerial disease (SMART) study: Rationale and design [J].
Simons, PCG ;
Algra, A ;
van de Laak, MF ;
Grobbee, DE ;
van der Graaf, Y .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1999, 15 (09) :773-781
[18]   One-year cardiovascular event rates in outpatients with atherothrombosis [J].
Steg, Ph. Gabriel ;
Bhatt, Deepak L. ;
Wilson, Peter W. F. ;
D'Agostino, Ralph, Sr. ;
Ohman, E. Magnus ;
Roether, Joachim ;
Liau, Chiau-Suong ;
Hirsch, Alan T. ;
Mas, Jean-Louis ;
Ikeda, Yasuo ;
Pencina, Michael J. ;
Goto, Shinya .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (11) :1197-1206
[19]   Risks of oral anticoagulant therapy with increasing age [J].
Torn, M ;
Bollen, WLEM ;
van der Meer, FM ;
van der Wall, EE ;
Rosendaal, FR .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (13) :1527-1532
[20]   Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease [J].
Tran, H ;
Anand, SS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (15) :1867-1874